| Literature DB >> 28801231 |
Kyu-Seon Oh1, Heta Patel1, Rachel A Gottschalk2, Wai Shing Lee1, Songjoon Baek3, Iain D C Fraser2, Gordon L Hager3, Myong-Hee Sung4.
Abstract
Despite the widespread use of glucocorticoids (GCs), their anti-inflammatory effects are not understood mechanistically. Numerous investigations have examined the effects of glucocorticoid receptor (GR) activation prior to inflammatory challenges. However, clinical situations are emulated by a GC intervention initiated in the midst of rampant inflammatory responses. To characterize the effects of a late GC treatment, we profiled macrophage transcriptional and chromatinscapes with Dexamethasone (Dex) treatment before or after stimulation by lipopolysaccharide (LPS). The late activation of GR had a similar gene-expression profile as from GR pre-activation, while ameliorating the disruption of metabolic genes. Chromatin occupancy of GR was not predictive of Dex-regulated gene expression, contradicting the "trans-repression by tethering" model. Rather, GR activation resulted in genome-wide blockade of NF-κB interaction with chromatin and directly induced inhibitors of NF-κB and AP-1. Our investigation using GC treatments with clinically relevant timing highlights mechanisms underlying GR actions for modulating the "inflamed epigenome." Published by Elsevier Inc.Entities:
Keywords: Glucocorticoids; NF-kappaB; chromatin; inflammation; macrophages; trans-repression
Mesh:
Substances:
Year: 2017 PMID: 28801231 PMCID: PMC5572836 DOI: 10.1016/j.immuni.2017.07.012
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745